Tag: invokana

Invokana Diabetic Ketoacidosis DKA Risk

Invokana Doubles Diabetic Ketoacidosis Risk, Study Finds

The diabetes drug Invokana has been linked to a doubled increased risk of ketoacidosis (too much acid in the blood) compared to diabetes drugs in the DPP-4 inhibitor class, according to a study published in the New England Journal of...

/ June 26, 2017
Canagliflozin FDA Foot Amputation Boxed Warning

Invokana Poses 2X Leg, Foot Amputation Risk: FDA Black Box Warning

The diabetes drug canagliflozin, the active ingredient in Invokana, Invokamet, and Invokamet XR, doubles the risk of amputations in diabetic foot disease, according to a new FDA Black Box warning label.

/ May 16, 2017
Invokans Lawsuits for Ketoacidosis and Kidney Failure

Invokana Lawsuits Centralized in New Jersey MDL

Nearly 100 lawsuits involving kidney failure, ketoacidosis, and other side effects of Janssen Pharmaceuticals' diabetes drugs Invokana and Invokamet have been centralized under one federal judge in New Jersey.

/ December 19, 2016

FDA Strengthens Kidney Warnings for Invokana, Other Diabetes Drugs

Diabetes patients on medications like Invokana have a higher risk of developing severe kidney problems, according to a new warning from the FDA.

/ June 14, 2016

Invokana Amputation Risk Under Review by FDA

FDA investigates study linking diabetes drugs Invokana and Invokamet with a doubled risk of leg, foot, and toe amputations.

/ May 20, 2016